IBC Site Activity Log




This page gives you a listing of everything that has happened on the site this month. The activity log for previous months can be accessed through the links below. There are no active document links.

    MA11.067a, Labiaplasty
    Policy Update
    Posted: 6/17/2015


    MA08.028a, Abatacept (Orencia®) for Injection for Intravenous Use
    Policy Update
    Posted: 6/17/2015


    MA08.027, Risperidone (Risperdal® Consta®) Injection
    Notification of Archive
    Posted: 6/17/2015


    MA09.010x, TEST Magnetic Resonance Imaging (MRI) Contrast Agents
    Notification of Archive
    Posted: 6/16/2015


    MA08.073a, Intravitreal Injection of Vascular Endothelial Growth Factor (VEGF) Antagonists (e.g., ranibizumab [Lucentis®], pegaptanib sodium [Macugen®], aflibercept [Eylea®])
    Notification
    Posted: 6/15/2015


    MA00.025, Reporting of Healthcare Common Procedure Coding System (HCPCS) C Series Codes
    Notification of Archive
    Posted: 6/12/2015


    MA00.025, Reporting of Healthcare Common Procedure Coding System (HCPCS) C Series Codes
    New Policy
    Posted: 6/12/2015


    MA11.059, Arthroscopic Lavage and Arthroscopic Debridement for the Osteoarthritic Knee
    Reissue
    Posted: 6/11/2015


    MA11.034, Collagen Meniscus Implant
    Reissue
    Posted: 6/11/2015


    MA05.042, Pulse Oximetry Device in the Home Setting
    Reissue
    Posted: 6/11/2015


    MA05.029, Heating Pads and Heat Lamps
    Reissue
    Posted: 6/11/2015


    MA05.028a, Durable Medical Equipment (DME) Not Subject to a Rental to Purchase Maximum
    Policy Update
    Posted: 6/8/2015


    MA11.105a, Aqueous Shunts, Viscocanalostomy, and Canaloplasty for the Treatment of Glaucoma
    Policy Update
    Posted: 6/3/2015


    MA11.093a, Surgical Treatments of Athletic Pubalgia
    Policy Update
    Posted: 6/3/2015


    MA08.022b, Rituximab (Rituxan®)
    Policy Update
    Posted: 6/3/2015


    MA08.059a, Ipilimumab (Yervoy®)
    Policy Update
    Posted: 6/3/2015


    MA08.010a, Programmed Cell Death Receptor-1 (PD-1) antagonists (e.g., Keytruda®, Opdivo®)
    Policy Update
    Posted: 6/3/2015


    MA08.058, Blinatumomab (Blincyto)
    Notification
    Posted: 6/3/2015


    MA05.053a, Implantable and External Infusion Pumps
    Notification
    Posted: 6/3/2015


    MA05.002a, Hospital Beds and Accessories
    Notification
    Posted: 6/3/2015


    MA11.023a, Hyaluronan Acid Therapies for Osteoarthritis of the Knee
    Notification
    Posted: 6/3/2015


    MA09.016, Digital Breast Tomosynthesis
    Notification of Archive
    Posted: 6/1/2015



    Issued on - 12/1/2000


Connect with Us        


© 2017 Independence Blue Cross.
Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association, serving the health insurance needs of Philadelphia and southeastern Pennsylvania.